Daclatasvir Medications

Daclatasvir Info

What is Daclatasvir?

Daclatasvir is an antiviral medicine that belongs to the class of direct-acting agents used to treat hepatitis C virus (HCV) infection. It works by stopping the virus from making new copies of itself, helping the body clear the infection. You will find daclatasvir in products such as Daklinza, Daclatasvir, and Natdac.

Medications with Daclatasvir

In Hong Kong, daclatasvir is marketed under several names:

• Daklinza - a tablet that contains daclatasvir alone and is often prescribed for different HCV genotypes.
• Daclatasvir - a generic version of the same active ingredient, available in tablet form.
• Natdac - another tablet formulation that provides the same antiviral component.

These products are supplied in various strengths, typically 30 mg or 60 mg tablets, and are taken orally. While the active ingredient is the same, the brand name and manufacturer may differ, which can affect price and availability in local pharmacies. All are approved for use by Hong Kong’s Department of Health under the Pharmaceutical Division’s regulations.

What Does Daclatasvir Treat?

Daclatasvir is primarily used to manage chronic hepatitis C infection. It is effective against several HCV genotypes, including genotype 1, 2, 3, 4, and 6, which are common in the region. The medication is usually part of a combination regimen, paired with other antivirals such as sofosbuvir, to achieve a higher cure rate.

• Chronic hepatitis C - Daclatasvir helps suppress the virus, allowing the liver to recover and reducing the risk of cirrhosis or liver cancer.
• Co-infection with HIV - In patients also living with HIV, daclatasvir can be included in a carefully managed treatment plan.
• Post-liver-transplant patients - Some clinicians may use daclatasvir to prevent recurrence of HCV after liver transplantation, following specialist guidance.

These uses are approved by health authorities in Hong Kong. Off-label applications are possible but should only be considered by a qualified healthcare professional.

How Daclatasvir Works

Daclatasvir blocks a protein that the hepatitis C virus needs to replicate its genetic material. By disabling this step, the drug reduces the amount of virus in the bloodstream. Most patients notice a decline in viral load within a few days of starting therapy, although the full treatment course usually lasts several weeks to achieve a sustained virological response.

Safety Information

Common Side Effects

People taking daclatasvir-containing tablets often report mild, temporary effects such as:

• Headache
• Fatigue or tiredness
• Nausea or mild stomach upset

These symptoms usually resolve on their own and do not require medical intervention unless they persist.

Serious Reactions

Rare but important reactions can occur, including:

• Severe allergic response (rash, swelling, difficulty breathing)
• Liver inflammation signs such as yellowing of the skin or eyes (jaundice)

If any of these appear, seek immediate medical help.

Who Should Be Cautious

Certain groups need to take extra care:

• People with severe liver dysfunction should discuss alternative options with their clinician.
• Patients who are pregnant or planning pregnancy must consult a healthcare professional, as safety data are limited.
• Individuals known to be allergic to daclatasvir or any of the tablet’s inactive ingredients should avoid these medicines.

Interaction Awareness

Daclatasvir may interact with other drug classes, including:

• Certain antibiotics and antifungal agents that affect liver enzymes
• Some antiretroviral medicines used for HIV treatment
• Alcohol, which can increase liver stress

It can also affect the effectiveness of hormonal contraceptives. Always review the full interaction list on the specific medication’s information page and discuss any over-the-counter products or supplements with a pharmacist.

What to Know Before Using

Store daclatasvir tablets at room temperature, away from excess moisture and direct sunlight. Treatment periods differ; some regimens last 12 weeks, while others may be shorter or longer depending on the combination used. Remember that each brand-Daklinza, Daclatasvir, Natdac-has its own prescribing details, so follow the instructions that come with your specific product. For comprehensive guidance on dosage, administration, and monitoring, refer to the individual medication’s patient information leaflet.

Information Disclaimer

This article offers general educational information about daclatasvir as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing daclatasvir may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.